Understanding Your Wegovy vs Mounjaro Treatment Options
Wegovy vs Mounjaro: Prescription Weight Loss Mechanisms Explained
When comparing Wegovy vs Mounjaro for prescription weight loss, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, helping reduce appetite and promote satiety after smaller meals. This prescription-only medicine works by targeting specific brain centres that control hunger and food cravings.
Mounjaro takes a different approach with its active ingredient tirzepatide, functioning as a dual GIP and GLP-1 receptor agonist. This dual mechanism may provide additional metabolic benefits beyond appetite suppression. Both treatments require administration alongside a reduced-calorie diet and increased physical activity, making them comprehensive prescription weight loss solutions rather than standalone treatments.
Wegovy vs Mounjaro Pricing: Treatment Costs and Value Bundles
Understanding the cost implications when choosing between Wegovy vs Mounjaro helps inform your prescription weight loss decision. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose (£209.99). Our Getting Started bundles provide convenient dose progression, such as the Intro Duo combining 0.25mg and 0.5mg for £169.99.
For extended treatment planning, our 3-pen bundles offer comprehensive coverage with options like the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99 or the Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25. Both Wegovy and Mounjaro require similar long-term commitment, making bundle pricing particularly relevant for sustained prescription weight loss treatment.
Clinical Evidence: Wegovy vs Mounjaro Research Outcomes
Clinical trials demonstrate that patients taking Wegovy alongside diet and exercise achieved significant weight loss outcomes. The STEP 1 trial showed approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 5 demonstrated sustained clinically studied weight loss maintained at 2 years. These results established Wegovy's position in prescription weight loss treatment protocols.
Mounjaro's clinical programme similarly demonstrated substantial weight management benefits in its trial population. When comparing Wegovy vs Mounjaro research, it's important to note that different trial designs, populations, and endpoints make direct percentage comparisons inappropriate. Both treatments have demonstrated clinically meaningful weight loss when used as prescribed, supporting their licensing for prescription weight loss in appropriate patients (Wilding et al., NEJM, 2021).
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy's semaglutide acts as a GLP-1 receptor agonist, binding to receptors found throughout your digestive system and brain. When you eat, this prescription-only medicine enhances the natural GLP-1 response, slowing gastric emptying so food remains in your stomach longer, promoting fullness. Simultaneously, Wegovy influences hypothalamic appetite centres, potentially reducing food cravings and the psychological drive to eat. The once-weekly FlexTouch pen delivers consistent medication levels, maintaining appetite suppression between doses. This mechanism makes Wegovy particularly effective for patients whose weight management challenges stem from portion control and frequent snacking patterns.
Starting Your Wegovy vs Mounjaro Treatment: The EverydayMeds Process
Beginning prescription weight loss treatment through EverydayMeds involves a streamlined 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers, operating under GPhC registration #9012878, review applications within 3 working days (or 24 hours with express service), determining suitability for either Wegovy or Mounjaro based on your individual circumstances. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our clinical team remains available throughout your treatment journey, monitoring progress and adjusting prescriptions as needed. This comprehensive approach ensures your Wegovy vs Mounjaro decision is supported by ongoing professional oversight rather than a one-time consultation.
Storage and Practical Considerations: Wegovy vs Mounjaro Handling
Storage requirements present a practical difference when comparing Wegovy vs Mounjaro for prescription weight loss. Wegovy pens must be refrigerated at 2-8°C before first use but offer superior travel flexibility, remaining stable at room temperature below 30°C for up to 6 weeks once removed from the fridge. Mounjaro provides only 21 days of room temperature stability, making Wegovy more suitable for patients with frequent travel or irregular schedules. Both treatments use pre-filled injection pens with simple once-weekly administration, though their dose escalation schedules differ. Wegovy follows a structured 16-week escalation from 0.25mg to 2.4mg maintenance, whilst Mounjaro uses its own titration protocol to minimise gastrointestinal side effects.
Wegovy vs Mounjaro: Prescription Weight Loss Treatment Pathways
The choice between Wegovy vs Mounjaro often depends on individual patient factors rather than one treatment being universally superior. Patients with type 2 diabetes may find their prescriber considers Mounjaro's dual mechanism potentially beneficial, whilst those prioritising travel convenience might prefer Wegovy's extended room temperature stability. Both treatments require commitment to lifestyle changes, making patient readiness for dietary modification and exercise equally important.
Your prescriber will consider factors including your medical history, concurrent medications, previous weight loss attempts, and practical lifestyle requirements when recommending between these prescription weight loss options. Some patients may trial one treatment before switching to the other based on tolerance or effectiveness, demonstrating that the Wegovy vs Mounjaro decision isn't necessarily permanent.
Complete Your Wegovy vs Mounjaro Assessment Today
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your prescription weight loss goals. Our 3-minute assessment considers all relevant factors in the Wegovy vs Mounjaro decision, ensuring you receive personalised treatment recommendations rather than generic protocols. New customers can begin their assessment today using discount code FIRST40, whilst returning customers benefit from code DOSE25 on their next order. Start your prescription weight loss journey with confidence, knowing our GPhC-registered clinical team supports your treatment from initial assessment through long-term weight management success. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and take the first step toward clinically-supported weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
